Join
Live feed
·
PRReleasevia Quantisnow
Standard BioTools Inc. logo

Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences

ByQuantisnow·Wall Street's wire, on your screen.
LAB· Standard BioTools Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LAB (Standard BioTools Inc.) and more on Quantisnow.